TENJUNCT Trademark

Trademark Overview


On Tuesday, September 4, 2018, a trademark application was filed for TENJUNCT with the United States Patent and Trademark Office. The USPTO has given the TENJUNCT trademark a serial number of 88103727. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 11, 2022. This trademark is owned by Eli Lilly and Company. The TENJUNCT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use i...
tenjunct

General Information


Serial Number88103727
Word MarkTENJUNCT
Filing DateTuesday, September 4, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
Translation of Words in MarkThe wording "TENJUNCT" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 11, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, April 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021EXTENSION 5 GRANTED
Monday, August 16, 2021EXTENSION 5 FILED
Monday, August 16, 2021TEAS EXTENSION RECEIVED
Saturday, February 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2021EXTENSION 4 GRANTED
Thursday, February 18, 2021EXTENSION 4 FILED
Thursday, February 18, 2021TEAS EXTENSION RECEIVED
Thursday, September 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 2, 2020EXTENSION 3 GRANTED
Monday, August 24, 2020EXTENSION 3 FILED
Tuesday, September 1, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 24, 2020TEAS EXTENSION RECEIVED
Wednesday, February 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2020EXTENSION 2 GRANTED
Monday, February 10, 2020EXTENSION 2 FILED
Monday, February 10, 2020TEAS EXTENSION RECEIVED
Friday, July 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 24, 2019EXTENSION 1 GRANTED
Wednesday, July 24, 2019EXTENSION 1 FILED
Wednesday, July 24, 2019TEAS EXTENSION RECEIVED
Tuesday, March 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 30, 2018ASSIGNED TO EXAMINER
Tuesday, September 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 7, 2018NEW APPLICATION ENTERED IN TRAM